GRN and posterior cortical atrophy: A growth factor commonly elevated in cancer, progranulin is known to present in the liquid biopsy (serum) of younger patients (<65 years) with PCa and can show potential as a prognostic biomarker since their elevated levels were linked to shorter overall survival in patients [25,26].